The 14th International Mouse Genome Conference will be held
in Narita, Japan, November 6 through November 10, 2000.
Registration and abstract deadline is July 15, 2000.
For further information, please see http://genome.rtc.riken.gojp/
IMGC2000.html or email: firstname.lastname@example.org.
Opportunity for Obtaining the Sequence of Mouse DNA of
Particularly High Biomedical Interest. Next Receipt Date: Au-
gust 1, 2000.
As part of the NIH Mouse Genome Sequencing Network’s effort
to determine the complete DNA sequence of the laboratory mouse,
strain C57BL/6J, the National Human Genome Research Institute
(NHGRI), has initiated a program that will allow investigators to
obtain the sequence of specific regions of the mouse genome.
While the initial emphasis of the Network will be on producing a
working draft sequence of the entire mouse genome, some of the
available sequencing capacity will be devoted to particular regions
which have special significance for advancing biomedical re-
search. Any investigator interested in obtaining the sequence of a
specific region of the mouse genome which has been identified in
the RPCI 23 BAC library may submit a short, Web-based request
describing the region, its importance, and its readiness to be se-
quenced. A panel of peer reviewers will consider the requests and
advise the NHGRI on the priority of the regions requested. Those
judged to be sufficiently important to warrant priority sequencing
will be listed for the centers engaged in mouse genomic sequenc-
ing to choose and sequence, up to the maximum capacity available
for this activity. There will be no cost to investigators seeking this
sequencing service; the sequencing will be done by centers that
have already been funded through the Network. However, as with
all sequence data generated by the Human Genome Project, un-
finished data will be submitted to GenBank within 24 hours of
generation of 2kb assemblies, and finished data as soon as com-
pleted. No sequence data will be made available to the requestor
prior to public release. All publications using this data must ac-
knowledge the publicly funded sequencing effort.
For a more complete description of the program and to access
the request form, please visit our website: http://www.nih.gov/
Submission Dates for 2000: February 1, April 1, June 1, August
1, October 1, December 1.
To discuss programmatic issues contact: Bettie J. Graham,
Ph.D., National Institutes of Health, Bethesda, MD 20892-2033.
Email: email@example.com; TEL: (301) 496-7531.
To discuss review issues contact: Jerry Roberts, Ph.D., National
Institutes of Health, Bethesda, MD 20892-2032. E-mail:
firstname.lastname@example.org; TEL: (301) 402-0838.
Call for Applications: Mouse Genotyping at the Center for In-
herited Disease Research (CIDR) (www.cidr.jhmi.edu <http://
The Center for Inherited Disease Research (CIDR) is an NIH-
supported resource providing high throughput genotyping ser-
vices to research efforts that are attempting to identify genetic
loci and allelic variants involved in human disease. Beginning
with the July 1, 2000 application submission deadline, the Center
will offer genotyping services to investigators conducting map-
ping studies with inbred strains of mice. Using DNA samples
provided by the principal investigator, CIDR will carry out ge-
nome-wide scans using automated fluorescent technology to ge-
notype microsatellite markers. All data will remain the property
of the principal investigator and will be returned once the studies
at CIDR are complete. A total of 47 inbred strains have been
typed. A list of the strains, along with allele sizes for ∼300 mark-
ers, is available on the CIDR web site. Only mouse map-
ping projects requesting whole genome scans totaling at least
10,000 genotypes (DNA sample × microsatellite marker) will be
CIDR is a joint effort by eleven participating institutes at NIH:
the National Cancer Institute (NCI), the National Eye Institute
(NEI), the National Human Genome Research Institute (NHGRI),
the National Institute on Aging (NIA), the National Institute of
Child Health and Human Development (NICHD), the National
Institute of Dental and Craniofacial Research (NIDCR), the Na-
tional Institute on Deafness and Other Communication Disorders
(NIDCD), the National Institute on Drug Abuse (NIDA), the Na-
tional Institute of Environmental Health Services (NIEHS), the
National Institute of Mental Health (NIMH), and the National
Institute of Neurological Disorders and Stroke (NINDS). CIDR is
located at the Bayview Research Campus of the Johns Hopkins
University and is operated by the University through a contract
from the NIH.
Investigators whose mapping projects are supported by one of
the eleven NIH Institutes participating in CIDR will receive free
genotyping. Other investigators are eligible to use CIDR on a fee
for service basis.
Access to CIDR is open to all investigators on a competi-
tive basis through peer review. For a more complete description
of CIDR, including specific application procedures, visit our Web-
site at http://www.cidr.jhmi.edu/ <http://www.cidr.jhmi.edu/>.
If you would like additional information, contact Dr. Jerry Ro-
berts, Scientific Review Administrator and Executive Director,
CIDR Board of Governors, in the NHGRI Office of Scientific
Application Deadlines: March 1, July 1, November 1.
© Springer-Verlag New York Inc. 2000Mammalian Genome 11, 608 (2000).